NPM1 and acute myeloid leukemia: Alteration of the NPM1 gene was found to be present at a high frequency in AML patients, ranging from 25% to 53% in all AML and 46% to 67% in CN-AML. NPM1-mutated AML consists of 27% of all AML and therefore forms the largest subgroup in this novel classification [18].